1. Home
  2. AWX vs IMNN Comparison

AWX vs IMNN Comparison

Compare AWX & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AWX

Avalon Holdings Corporation

HOLD

Current Price

$2.46

Market Cap

10.3M

Sector

Utilities

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$1.71

Market Cap

8.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AWX
IMNN
Founded
1998
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Environmental Services
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3M
8.4M
IPO Year
1998
2000

Fundamental Metrics

Financial Performance
Metric
AWX
IMNN
Price
$2.46
$1.71
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
5.1K
48.0K
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$53,090,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3.14
N/A
52 Week Low
$2.40
$0.48
52 Week High
$5.43
$9.32

Technical Indicators

Market Signals
Indicator
AWX
IMNN
Relative Strength Index (RSI) 46.23 16.80
Support Level N/A N/A
Resistance Level $2.64 $3.24
Average True Range (ATR) 0.08 0.14
MACD -0.00 -0.00
Stochastic Oscillator 19.23 4.17

Price Performance

Historical Comparison
AWX
IMNN

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Share on Social Networks: